PNC FINANCIAL SERVICES GROUP, INC. - PROPHASE LABS INC ownership

PROPHASE LABS INC's ticker is PRPH and the CUSIP is 74345W108. A total of 13 filers reported holding PROPHASE LABS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of PROPHASE LABS INC
ValueSharesWeighting
Q4 2021$4,000
-95.5%
600
-97.6%
0.00%
Q3 2020$88,000
+144.4%
25,4020.0%0.00%
Q2 2020$36,000
-25.0%
25,4020.0%0.00%
Q1 2020$48,000
-4.0%
25,4020.0%0.00%
Q4 2019$50,0000.0%25,4020.0%0.00%
Q3 2019$50,000
-7.4%
25,4020.0%0.00%
Q2 2019$54,000
-28.9%
25,4020.0%0.00%
Q1 2019$76,000
-5.0%
25,4020.0%0.00%
Q4 2018$80,000
+5.3%
25,4020.0%0.00%
Q3 2018$76,000
-7.3%
25,4020.0%0.00%
Q2 2018$82,000
+7.9%
25,4020.0%0.00%
Q1 2018$76,000
+35.7%
25,4020.0%0.00%
Q4 2017$56,000
+3.7%
25,4020.0%0.00%
Q3 2017$54,000
-35.7%
25,402
-36.5%
0.00%
Q2 2017$84,000
-37.8%
40,000
-33.3%
0.00%
Q1 2017$135,000
+12.5%
60,0000.0%0.00%
Q4 2016$120,000
+2.6%
60,0000.0%0.00%
Q3 2016$117,000
+50.0%
60,0000.0%0.00%
Q2 2016$78,000
-7.1%
60,0000.0%0.00%
Q1 2016$84,000
-6.7%
60,000
-0.2%
0.00%
Q4 2015$90,000
-6.2%
60,100
+0.2%
0.00%
Q3 2015$96,000
+18.5%
60,0000.0%0.00%
Q2 2015$81,000
+3.8%
60,0000.0%0.00%
Q1 2015$78,000
-10.3%
60,0000.0%0.00%
Q4 2014$87,000
+3.6%
60,0000.0%0.00%
Q3 2014$84,000
-17.6%
60,0000.0%0.00%
Q2 2014$102,000
-15.0%
60,0000.0%0.00%
Q1 2014$120,000
+25.0%
60,0000.0%0.00%
Q4 2013$96,000
-15.8%
60,0000.0%0.00%
Q3 2013$114,000
+22.6%
60,0000.0%0.00%
Q2 2013$93,00060,0000.00%
Other shareholders
PROPHASE LABS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Renaissance Technologies 219,510$760,0000.00%
ROYAL BANK OF CANADA 130$00.00%
VANGUARD GROUP INC 42,127$146,0000.00%
Advisory Services Network, LLC 600$2,0000.00%
UBS Group AG 5,103$18,0000.00%
COMMONWEALTH EQUITY SERVICES, LLC 16,936$58,0000.00%
BANK OF AMERICA CORP /DE/ 23$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 25,402$88,0000.00%
WELLS FARGO & COMPANY/MN 54$00.00%
NORTHERN TRUST CORP 40,606$141,0000.00%
View complete list of PROPHASE LABS INC shareholders